EUVIMEDEUVIMED entdecken
Crossref

Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy

Rong Fu, Fuyuan Zhang, Jingran Fu, Yuqian Li, Xuanzhe Zhu, Qian Ding, Yi-Zhun Zhu

Metabolism and Target Organ Damage · 16.12.2025 · 5 (4)

DOI: 10.20517/mtod.2025.163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 16.12.2025. Verfasst von Rong Fu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 188 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatohepatitis (MASH) represents a progressive liver disease of a rapidly increasing global prevalence, driven by intricate pathophysiological interactions within the hepatic microenvironment and systemic crosstalk between the liver and peripheral organs. This review delineates the dynamic roles of key hepatic effector cells, including hepatocytes, liver sinusoidal endothelial cells, Kupffer cells, and hepatic stellate cells, in disease initiation and progression, highlighting how their dysregulated intercellular communication through soluble mediators and extracellular vesicles perpetuates a vicious cycle of lipotoxicity, inflammation, and fibrosis. Furthermore, we expound on the critical involvement of extrahepatic organ networks, specifically the gut-liver, adipose-liver, and muscle-liver axes, in exacerbating hepatic metabolic dysregulation via microbial dysbiosis, aberrant adipokine secretion, and myokine imbalances. The repeated failure of highly selective, single-target therapies in clinical trials underscores the multifactorial nature of MASH pathogenesis and necessitates a paradigm shift in therapeutic strategies. We propose that future innovations should embrace two novel perspectives: first, the development of multi-target agents capable of simultaneously rectifying aberrant multicellular crosstalk within the hepatic microenvironment; and second, the modulation of dynamic interplay between the liver and other organs to restore systemic metabolic homeostasis. Ultimately, integrating such multi-target approaches with precision medicine tailored to individual genetic and phenotypic profiles holds the key to curbing the growing MASH epidemic.

Zitieren

APA

Fu, R., Zhang, F., Fu, J., Li, Y., Zhu, X., Ding, Q., & Zhu, Y. (2025). Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy. Metabolism and Target Organ Damage, 5(4). https://doi.org/10.20517/mtod.2025.163

Vancouver

Fu R, Zhang F, Fu J, Li Y, Zhu X, Ding Q, et al. Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy. Metabolism and Target Organ Damage. 2025;5(4). doi:10.20517/mtod.2025.163

BibTeX
@article{Fu2025,
  author = {Fu, Rong and Zhang, Fuyuan and Fu, Jingran and Li, Yuqian and Zhu, Xuanzhe and Ding, Qian and Zhu, Yi-Zhun},
  title = {Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy},
  journal = {Metabolism and Target Organ Damage},
  year = {2025},
  volume = {5},
  number = {4},
  doi = {10.20517/mtod.2025.163}
}
Kostenlos starten →